These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10507006)

  • 1. Crystallographic analysis of solvent-trapped intermediates of chymotrypsin.
    Farber GK
    Methods Enzymol; 1999; 308():201-15. PubMed ID: 10507006
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrophobic bonding and conformational transitions in lysozyme, ribonuclease and chymotrypsin.
    FOSS JG
    Biochim Biophys Acta; 1961 Mar; 47():569-79. PubMed ID: 13700946
    [No Abstract]   [Full Text] [Related]  

  • 3. Incorporation of crystallographic temperature factors in the statistical analysis of protein tertiary structures.
    Bott R; Frane J
    Protein Eng; 1990 Aug; 3(8):649-57. PubMed ID: 2217138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accessibility of proteins in protein-SDS complexes.
    Law CJ; Price NC
    Biochem Soc Trans; 1996 May; 24(2):323S. PubMed ID: 8736981
    [No Abstract]   [Full Text] [Related]  

  • 5. Local densities orthogonal to beta-sheet amide planes: patterns of packing in globular proteins.
    Beardsley DS; Kauzmann WJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4448-53. PubMed ID: 8633087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
    Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
    Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein densities from X-ray crystallographic coordinates.
    Kauzmann W; Moore K; Schultz D
    Nature; 1974 Mar; 248(447):447-9. PubMed ID: 4823675
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystallization and preliminary X-ray crystallographic analysis of the protease inhibitor ecotin in complex with chymotrypsin.
    Lee CS; Seong IS; Song HK; Chung CH; Suh SW
    Acta Crystallogr D Biol Crystallogr; 1999 May; 55(Pt 5):1091-2. PubMed ID: 10216315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure determination and analysis of a bacterial chymotrypsin from Cellulomonas bogoriensis.
    Shaw A; Saldajeno ML; Kolkman MA; Jones BE; Bott R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Apr; 63(Pt 4):266-9. PubMed ID: 17401191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification, crystallization and preliminary crystallographic studies of SPCI-chymotrypsin complex at 2.8 A resolution.
    da Silva AJ; Teles RC; Esteves GF; dos Santos CR; Barbosa JA; de Freitas SM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Oct; 64(Pt 10):914-7. PubMed ID: 18931434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ensemble of crystallographic models enables the description of novel bromate-oxoanion species trapped within a protein crystal.
    Ondrácek J; Mesters JR
    Acta Crystallogr D Biol Crystallogr; 2006 Sep; 62(Pt 9):996-1001. PubMed ID: 16929100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray crystal structure of a dipeptide-chymotrypsin complex in an inhibitory interaction.
    Kashima A; Inoue Y; Sugio S; Maeda I; Nose T; Shimohigashi Y
    Eur J Biochem; 1998 Jul; 255(1):12-23. PubMed ID: 9692896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-chymotrypsin is a complex of alpha-chymotrypsin with its own autolysis products.
    Harel M; Su CT; Frolow F; Silman I; Sussman JL
    Biochemistry; 1991 May; 30(21):5217-25. PubMed ID: 2036388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some electrospray mass spectrometric evidence for the existence of covalent O-acyl enzyme intermediates.
    Ashton DS; Beddell CR; Cooper DJ; Green BN; Oliver RW; Welham KJ
    FEBS Lett; 1991 Nov; 292(1-2):201-4. PubMed ID: 1959607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization and preliminary X-ray crystallographic study of the leech protease inhibitor guamerin and its complex with bovine pancreatic chymotrypsin.
    Kim DR; Kim DY; Chu TT; Jung KH; Kim KK
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):285-7. PubMed ID: 15158739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and solvation of Thr/Ser to Ala and Gly mutations at the N-cap of alpha-helices.
    Chen YW; Fersht AR
    FEBS Lett; 1994 Jun; 347(2-3):304-9. PubMed ID: 8034023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of x-ray structural analysis data for evaluating the contribution of beta-structures to the optical rotatory dispersion of proteins].
    Troitskiĭ GV; Zav'ialov VP
    Biofizika; 1973; 18(6):986-91. PubMed ID: 4142398
    [No Abstract]   [Full Text] [Related]  

  • 18. Active site dynamics of acyl-chymotrypsin.
    Nakagawa S; Yu HA; Karplus M; Umeyama H
    Proteins; 1993 Jun; 16(2):172-94. PubMed ID: 8332606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins.
    Chou PY; Fasman GD
    Biochemistry; 1974 Jan; 13(2):211-22. PubMed ID: 4358939
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.
    Radisky ES; Lu CJ; Kwan G; Koshland DE
    Biochemistry; 2005 May; 44(18):6823-30. PubMed ID: 15865427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.